Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS, Hricak H, Zelefsky MJ, Akin O. Donati OF, et al. Among authors: gultekin dh. Radiology. 2013 Aug;268(2):440-50. doi: 10.1148/radiol.13122149. Epub 2013 Mar 12. Radiology. 2013. PMID: 23481164 Free PMC article.
Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results.
Akin O, Gultekin DH, Vargas HA, Zheng J, Moskowitz C, Pei X, Sperling D, Schwartz LH, Hricak H, Zelefsky MJ. Akin O, et al. Among authors: gultekin dh. Eur Radiol. 2011 Sep;21(9):1970-8. doi: 10.1007/s00330-011-2130-6. Epub 2011 May 1. Eur Radiol. 2011. PMID: 21533634 Free PMC article.
Prognostic aspects of DCE-MRI in recurrent rectal cancer.
Gollub MJ, Cao K, Gultekin DH, Kuk D, Gonen M, Sohn M, Schwartz LH, Weiser MR, Temple LK, Nash GM, Guillem JG, Wang M, Garcia-Aguilar J, Goodman K, Paty PB. Gollub MJ, et al. Among authors: gultekin dh. Eur Radiol. 2013 Dec;23(12):3336-44. doi: 10.1007/s00330-013-2984-x. Epub 2013 Aug 27. Eur Radiol. 2013. PMID: 23979104
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.
Jarnagin WR, Schwartz LH, Gultekin DH, Gönen M, Haviland D, Shia J, D'Angelica M, Fong Y, DeMatteo R, Tse A, Blumgart LH, Kemeny N. Jarnagin WR, et al. Among authors: gultekin dh. Ann Oncol. 2009 Sep;20(9):1589-1595. doi: 10.1093/annonc/mdp029. Epub 2009 Jun 2. Ann Oncol. 2009. PMID: 19491285 Free PMC article. Clinical Trial.
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Gollub MJ, Gultekin DH, Akin O, Do RK, Fuqua JL 3rd, Gonen M, Kuk D, Weiser M, Saltz L, Schrag D, Goodman K, Paty P, Guillem J, Nash GM, Temple L, Shia J, Schwartz LH. Gollub MJ, et al. Among authors: gultekin dh. Eur Radiol. 2012 Apr;22(4):821-31. doi: 10.1007/s00330-011-2321-1. Epub 2011 Nov 20. Eur Radiol. 2012. PMID: 22101743
Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.
Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Konstantinidis IT, et al. Among authors: gultekin dh. Ann Surg Oncol. 2014 Aug;21(8):2675-83. doi: 10.1245/s10434-014-3649-y. Epub 2014 Mar 25. Ann Surg Oncol. 2014. PMID: 24664624 Free PMC article. Clinical Trial.
16 results